EP1539100A4 - Composition and methods for the treatment of skin disorders - Google Patents

Composition and methods for the treatment of skin disorders

Info

Publication number
EP1539100A4
EP1539100A4 EP03764101A EP03764101A EP1539100A4 EP 1539100 A4 EP1539100 A4 EP 1539100A4 EP 03764101 A EP03764101 A EP 03764101A EP 03764101 A EP03764101 A EP 03764101A EP 1539100 A4 EP1539100 A4 EP 1539100A4
Authority
EP
European Patent Office
Prior art keywords
treatment
composition
methods
skin disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03764101A
Other languages
German (de)
French (fr)
Other versions
EP1539100A2 (en
Inventor
Avikam Harel
Olga Bloch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermipsor Ltd
Original Assignee
Dermipsor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/192,842 external-priority patent/US20030032617A1/en
Application filed by Dermipsor Ltd filed Critical Dermipsor Ltd
Publication of EP1539100A2 publication Critical patent/EP1539100A2/en
Publication of EP1539100A4 publication Critical patent/EP1539100A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
EP03764101A 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders Withdrawn EP1539100A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US192842 2002-07-11
US10/192,842 US20030032617A1 (en) 2000-01-11 2002-07-11 Composition and methods for the treatment of skin disorders
PCT/IL2003/000576 WO2004006887A2 (en) 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders

Publications (2)

Publication Number Publication Date
EP1539100A2 EP1539100A2 (en) 2005-06-15
EP1539100A4 true EP1539100A4 (en) 2006-01-18

Family

ID=30114413

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03764101A Withdrawn EP1539100A4 (en) 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders

Country Status (4)

Country Link
EP (1) EP1539100A4 (en)
AU (1) AU2003242965B2 (en)
CA (1) CA2492248A1 (en)
WO (1) WO2004006887A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006120682A2 (en) * 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
CA2569279A1 (en) * 2004-06-04 2005-12-15 Chemgenex Pharmaceuticals, Inc. Methods of treating cellular proliferative disease using naphthalimide and parp-1 inhibitors
US8034788B2 (en) 2005-05-10 2011-10-11 Dermipsor Ltd. Composition and methods for skin care
WO2014059034A2 (en) 2012-10-09 2014-04-17 President And Fellows Of Harvard College Nad biosynthesis and precursors for the treatment and prevention of cancer and proliferation
CN108836965A (en) 2018-08-07 2018-11-20 浙江大学 Application of the niacinamide composition in preparation treatment Sorafenib hand-foot skin reaction drug

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052705A1 (en) * 1980-11-24 1982-06-02 Joel E. Bernstein, M.D. Composition for treating acne vulgaris
DE4335454A1 (en) * 1993-10-19 1995-04-20 Schleicher Peter Geriatric medical composition
WO1998052529A1 (en) * 1997-05-23 1998-11-26 The Procter & Gamble Company Skin care compositions comprising vitamin b3 and a skin conditioning component
DE29916231U1 (en) * 1999-09-15 2000-02-17 Renner Jobst Multivitamin and mineral preparation
US20030032617A1 (en) * 2000-01-11 2003-02-13 Avikam Harel Composition and methods for the treatment of skin disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US5831074A (en) * 1988-11-02 1998-11-03 Strumwasser; Felix Eucaryotic NAD cyclases
JPH05163160A (en) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd Nutrient preparation for prevention and treatment of infectious disease caused by immune depression
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052705A1 (en) * 1980-11-24 1982-06-02 Joel E. Bernstein, M.D. Composition for treating acne vulgaris
DE4335454A1 (en) * 1993-10-19 1995-04-20 Schleicher Peter Geriatric medical composition
WO1998052529A1 (en) * 1997-05-23 1998-11-26 The Procter & Gamble Company Skin care compositions comprising vitamin b3 and a skin conditioning component
DE29916231U1 (en) * 1999-09-15 2000-02-17 Renner Jobst Multivitamin and mineral preparation
US20030032617A1 (en) * 2000-01-11 2003-02-13 Avikam Harel Composition and methods for the treatment of skin disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Dermtaological prepn. contg. water soluble deriv. of retinol - useful for treating hyper-keratosis and preventing wrinkles is safe and stable", WPI WORLD PATENT INFORMATION DERWENT, DERWENT, GB, vol. 21, no. 96 PA - NOEVIR PN - JP8073338 A, 19 March 1996 (1996-03-19), XP002041731 *
MORIMOTO S ET AL: "AN OPEN STUDY OF VITAMIN D3 TREATMENT IN PSORIASIS VULGARIS", BRITISH JOURNAL OF DERMATOLOGY, vol. 115, no. 2, 1986, pages 421 - 429, XP000905334, ISSN: 0007-0963 *

Also Published As

Publication number Publication date
AU2003242965A1 (en) 2004-02-02
CA2492248A1 (en) 2004-01-22
EP1539100A2 (en) 2005-06-15
WO2004006887A2 (en) 2004-01-22
AU2003242965B2 (en) 2009-02-05
WO2004006887A3 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
AU2003286567A8 (en) Methods for the treatment of skin disorders
EP1509279A4 (en) Device and method for the treatment of cardiac disorders
IL178142A0 (en) Methods of using and compositions comprising immunomodulatory compounos for the treatment and management of skin diseases or disorders
IL175529A0 (en) Methods and compositions for the treatment of metabolic disorders
EP1641378A4 (en) Methods and devices for the treatment of skin lesions
EP1571968A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1589933A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1575480A4 (en) Compositions and methods for the treatment of immune related diseases
EP1578367A4 (en) Compositions and methods for the treatment of immune related diseases
EP1572116A4 (en) Compositions and methods for the treatment of immune related diseases
EP1576137A4 (en) Compositions and methods for the treatment of immune related diseases
EP1572091A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1578996A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1553912A4 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003278775A8 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
EP1560593A4 (en) Novel composition and methods for the treatment of immune related diseases
EP1575571A4 (en) Compositions and methods for the diagnosis and treatment of tumor
HK1203216A1 (en) Materials and methods for treating disorders of the ear
ZA200410401B (en) Use of thio-oxindole derivatives in treatment of skin disorders
AU2003228819A8 (en) Combinations for the treatment of inflammatory skin disorders
IL165397A0 (en) Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
EP1478438A4 (en) Methods and compositions for the treatment of asthma and related disorders
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
EP1648399A4 (en) Method and topical composition for the treatment of hyperpigmented skin
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050210

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20051205

17Q First examination report despatched

Effective date: 20100930

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110211